Exploring Psilocybin’s Impact on Fertility
Brian Johnson, a notable figure in the biohacking community, is often in the spotlight for his bold assertions about health and aging. Reports suggest he invests around $2 million annually with the aim of reversing his biological age.
His recent focus has shifted to psilocybin—commonly referred to as magic mushrooms. While many hail it as a potential magic bullet for extending life and alleviating conditions like Parkinson’s, Johnson has uncovered what he interprets as the first indication of its negative impacts on male fertility.
The compound found in certain mushrooms is becoming increasingly popular, but Johnson’s findings are rather alarming. He undertook a personal experiment, consuming two doses of psilocybin—25 milligrams followed by 28 milligrams—though the timing between these doses was not disclosed.
Initially, Johnson’s sperm count was extraordinarily high, situated at the 99.6th percentile for men his age. However, just three days after he took his second dose, the motility of his sperm—crucially, their ability to move effectively—dropped by 51%, placing him at the 77.7th percentile. Interestingly, the overall number of sperm seemed stable, dipping by only 2%.
The implications continued, as Johnson observed that his sperm morphology, an essential factor in fertility, also halved in quality.
There was a slight recovery in some metrics 20 days post-treatment, but his baseline of 600 milligrams fell to 373 milligrams—a significant drop that raised questions about the long-term effects of psilocybin on reproductive health.
Interestingly, the changes seemed connected to his testosterone levels. Just three days following the second dose, Johnson’s total serum testosterone spiked by 30%, while his sex hormone binding globulin (SHBG) surged by 37%. This protein is responsible for transporting sex hormones in the bloodstream, which is crucial for sperm production. But, elevated levels can lead to feelings of fatigue and a decrease in libido.
In a twist, Johnson’s free testosterone—what’s readily available for the body—declined by 24% shortly after the second dose and then another 23% by the 20-day mark. Despite these reductions, he downplays their significance, arguing that the positive metabolic and anti-inflammatory effects of psilocybin surpass any potential concerns about lowered sperm count.
He points out that these results mark a significant first in the field, claiming, “to our knowledge, there are no published human clinical studies demonstrating that psilocybin reduces markers of male fertility.” This opens a conversation about whether the risks of psychedelic substances like psilocybin on fertility have been overlooked, especially as past studies mainly concentrated on the impact of recreational drugs on overall hormonal balance rather than direct influences on fertility itself.
Still, one can’t help but wonder: What does this mean for the future of psilocybin research and its possible applications in the field of health and wellness?
